Merck KGaA
MRK.DE · XETRA
Market closed€136.30€-1.65 (-1.20%)
Key statistics
Previous close€137.95
Open€138.15
Day high€139.05
Day low€134.30
52-week high€148.65
52-week low€100.70
Market cap59.22B
Volume326.17K
Average volume359.29K
P/E ratio16.23
Forward P/E—
EPS8.40
Dividend yield+1.61%
Market context
Why it moved
Merck KGaA (XTRA:MRK) edged lower despite broadly positive news, including the opening of a new BioReliance testing facility in Darmstadt, a European label update for Erbitux, and an FDA Breakthrough Therapy designation for enpatoran, as investors appear to be taking profits amid lingering concerns over long-term execution risks and the stock's multi-year underperformance.
What is happening
Recent company-specific developments and publisher coverage.
Simply Wall Street · July 19, 2026Merck KGaA (XTRA:MRK) Could Be 5% Undervalued Following Its BioReliance Facility OpeningGlobes - Israel Business News · July 19, 2026Merck downsizing two Israeli development centerswww.marketscreener.com · July 16, 2026Merck KGaA invests €25m in a new testing center in GermanyNews-Medical · June 26, 2026Merck KGaA, Darmstadt, Germany, agrees to acquire Bio-Techne, strengthening leadership position in fast-growing life sciences marketsInvesting News Network · June 25, 2026Merck KGaA to Acquire Bio-Techne in US$11.3 Billion DealGenetic Engineering and Biotechnology News · June 25, 2026Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools PresencePR Newswire · June 25, 2026Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences MarketsCBS News · June 25, 2026Bio-Techne, a Minneapolis life sciences firm with 500,000 products, to be sold to German company for $11.3 billion Mt Newswire · July 16, 2026Merck KGaA Opens New Testing Facility at German HQ Mt Newswire · July 14, 2026EU OKs Expanded Erbitux Use for BRAF V600E-Mutant Metastatic Colorectal Cancer Mt Newswire · July 8, 2026Merck KGaA's Lupus Drug Gets US FDA Breakthrough Therapy Designation Mt Newswire · June 26, 2026BofA Says Merck KGaA's Planned Bio-Techne Acquisition 'Strategically, Financially Sensible' Benzinga · June 25, 2026Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal Mt Newswire · June 25, 2026Merck KGaA to Buy US-based Bio-Techne in $11.3 Billion Deal Mt Newswire · June 25, 2026Merck KGaA to Buy Life Science Tools Group Bio-Techne in $11.3 Billion Deal Mt Newswire · June 23, 2026Merck KGaA Partners with Biotech Co for Cardiomyopathies Treatment Research